Pingora Partners’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Sell
134,747
-6,900
-5% -$77K 0.72% 33
2026
Q1
$1.53M Sell
141,647
-1,400
-1% -$12K 0.91% 26
2025
Q4
$874K Buy
143,047
+122,600
+600% +$732K 0.53% 37
2025
Q3
$106K Hold
20,447
0.07% 94
2025
Q2
$121K Hold
20,447
0.09% 88
2025
Q1
$168K Sell
20,447
-2,256
-10% -$18.9K 0.12% 71
2024
Q4
$188K Hold
22,703
0.12% 69
2024
Q3
$174K Hold
22,703
0.12% 72
2024
Q2
$235K Hold
22,703
0.17% 63
2024
Q1
$271K Hold
22,703
0.2% 62
2023
Q4
$245K Buy
+22,703
New +$276K 0.22% 61

Other funds holding PTEN

Pingora Partners's PTEN Position: Q2 2026 in Review

Pingora Partners reduced its Patterson-UTI (PTEN) stake by 4.9% in Q2 2026, selling an estimated $77K and leaving 134,747 shares worth $1.24M. The position accounts for 0.72% of the portfolio, ranked #33.

Pingora Partners first reported a position in PTEN in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.53M in Q1 2026. 438 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Pingora Partners held 134,747 shares of Patterson-UTI worth $1.24M as of Q2 2026.
  • Pingora Partners sold 6,900 Patterson-UTI shares in Q2 2026, an estimated $77K.
  • Patterson-UTI made up 0.72% of Pingora Partners's portfolio in Q2 2026, its #33 holding.
  • Pingora Partners first reported a position in Patterson-UTI in Q4 2023 and has held it in 11 quarters since.
  • Pingora Partners's Patterson-UTI position peaked at $1.53M in Q1 2026.
  • 438 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Pingora Partners's 13F filing for Q2 2026, filed 14 Aug 2026.